Collegium Payables Turnover from 2010 to 2024
| COLL Stock | USD 32.47 1.20 3.56% |
Payables Turnover | First Reported 2010-12-31 | Previous Quarter 27.68039577 | Current Value 29.06 | Quarterly Volatility 9.60940834 |
Check Collegium Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Collegium main balance sheet or income statement drivers, such as Depreciation And Amortization of 156.7 M, Interest Expense of 87.5 M or Selling General Administrative of 97.6 M, as well as many exotic indicators such as Price To Sales Ratio of 1.74, Dividend Yield of 0.0 or PTB Ratio of 5.18. Collegium financial statements analysis is a perfect complement when working with Collegium Pharmaceutical Valuation or Volatility modules.
Collegium | Payables Turnover |
Latest Collegium Pharmaceutical's Payables Turnover Growth Pattern
Below is the plot of the Payables Turnover of Collegium Pharmaceutical over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Collegium Pharmaceutical's Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Collegium Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
| Payables Turnover | 10 Years Trend |
|
Payables Turnover |
| Timeline |
Collegium Payables Turnover Regression Statistics
| Arithmetic Mean | 5.33 | |
| Geometric Mean | 0.31 | |
| Coefficient Of Variation | 180.20 | |
| Mean Deviation | 6.29 | |
| Median | 0.46 | |
| Standard Deviation | 9.61 | |
| Sample Variance | 92.34 | |
| Range | 29.0482 | |
| R-Value | 0.73 | |
| Mean Square Error | 45.94 | |
| R-Squared | 0.54 | |
| Significance | 0 | |
| Slope | 1.58 | |
| Total Sum of Squares | 1,293 |
Collegium Payables Turnover History
About Collegium Pharmaceutical Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Collegium Pharmaceutical income statement, its balance sheet, and the statement of cash flows. Collegium Pharmaceutical investors use historical funamental indicators, such as Collegium Pharmaceutical's Payables Turnover, to determine how well the company is positioned to perform in the future. Although Collegium Pharmaceutical investors may use each financial statement separately, they are all related. The changes in Collegium Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Collegium Pharmaceutical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Collegium Pharmaceutical Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Collegium Pharmaceutical. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Payables Turnover | 27.68 | 29.06 |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Collegium Pharmaceutical using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Collegium Pharmaceutical Correlation against competitors. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Collegium Stock analysis
When running Collegium Pharmaceutical's price analysis, check to measure Collegium Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collegium Pharmaceutical is operating at the current time. Most of Collegium Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Collegium Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collegium Pharmaceutical's price. Additionally, you may evaluate how the addition of Collegium Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Collegium Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 51.976 | Earnings Share 2.51 | Revenue Per Share 17.054 | Quarterly Revenue Growth 0.001 | Return On Assets 0.1056 |
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.